« Previous
Next »
The Journal of Urology
Volume 181, Issue 1
, Pages 105-112
, January 2009
Visually Directed Transrectal High Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Preliminary Report on the Italian Experience
References
- . Population aging and cancer: a cross-national concern. Cancer J. 2005;11:437
- . Histological and cerebral lesions produced by focused ultrasound. Ann J Pathol. 1944;20:637
- . Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res. 1995;55:3346
- Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol. 1996;29:174
- Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969
- . Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: a proposed standard for the conduct of therapy. BJU Int. 2006;98:1187
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965
- . Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life. BJU Int. 2005;96:43
- . Cryosurgery in the management of prostate cancer. Actas Urol Esp. 2007;31:211
- . Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique. Am J Clin Oncol. 2007;30:215
- . High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology. 2004;63:297
- . High-intensity focused ultrasound (HIFU) for prostate cancer. Cancer Control. 2007;14:244
- Short-term out come after hig-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. BJU Int. 2006;98:1193
- Efficacy of short-term androgen deprivation with high-intensity focused ultrasound in the treatment of prostate cancer in Japan. Urology. 2008;Epub ahead of print
- Consensus statement: guidelines for PSA following radiation therapy (American Society for Therapeutic Radiology and Oncology Consensus Panel). Int J Radiat Oncol Biol Phys. 1997;37:1035
- . Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int. 2006;97:56
- First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol. 2008;53:1194
- . The evolving role of prostate brachytherapy. Cancer Control. 2001;8:163
- . To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?. BJU Int. 2006;98:537
- PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol. 2008;53:547
- . Brachytherapy for carcinoma of the prostate: techniques, patient selection, and clinical outcomes. Semin Radiat Oncol. 2002;12:81
- . Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.. Int J Radiat Oncol Biol Phys. 2000;47:1261
For another article on a related topic see page 354.
PII: S0022-5347(08)02444-0
doi: 10.1016/j.juro.2008.09.024
© 2009 American Urological Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Urology
Volume 181, Issue 1
, Pages 105-112
, January 2009

